From Silicon to Solutions: The Role of Chiptech in Modern Medicine

The rapid advancement of chip technology has revolutionized various sectors, with modern medicine being one of the most significantly impacted. This session will explore the transformative effects of Chiptech on healthcare delivery, diagnostics, and treatment. Attendees will gain insights into how cutting-edge semiconductor innovations are enabling the development of more precise diagnostic tools, personalized medicine, and advanced therapeutic solutions. The session will feature leading experts in the field who will discuss the latest breakthroughs, current applications, and future potential of Chiptech in medicine. By delving into case studies and real-world applications, participants will learn how these technologies are improving patient outcomes and shaping the future of healthcare.

General information

Time: 11.00 - 12.00
Language: English
Room: MAIN STAGE (TL 2275 | First floor)
Available seats: 250

The programme

11.00 - 11.05	Welcome & Opening Twan Korthorst, New Origin
11.05 - 11.15	The MEMS Ultrasound Revolution Ronald Dekker, Phillips
11.15 - 11.25	Talk 2 Martin Bennink, Saxion University of Applied Science
11.25 - 11.35	Talk 3 Albert van den Berg, University of twente
11.35 - 11.55	Panel discussion with all speakers moderated by Twan Korthorst, New Origin
11.55 - 12.00	Closing words

Speakers

Albert van den Berg | University of Twente

Prof. Dr. Ir. Albert van den Berg received his MSc and PhD from the University of Twente. He worked on miniaturized chemical sensors in Switzerland and became a full professor in 2000 at the MESA+ Institute for Nanotechnology. He co-founded the MicroTAS conference series and has published over 500 peer-reviewed articles, leading to more than 10 spin-off companies. His awards include multiple ERC grants and membership in the Royal Dutch Academy of Sciences. He was the scientific director of the MIRA Institute (2014-2018) and is currently focused on micro/nanofluidics, health sustainability, and organs-on-chip.

Martin Bennink | Saxion University of Applied Sciences

Since 2016 professor (lector) Applied Nanotechnology, chairing a research group in application-driven, multidisciplinary research projects at interface of nanotechnology and life sciences. Projects are in close collaboration with industry, SMEs and other societal partners, aimed at societal challenges: health/wellbeing, security/environment. Current research lines: molecular sensing technologies, lab-on-a-chip / organ-on-a-chip, (iii) nanomaterials, (iv) societal embedding.

Ronald Dekker, Phillips

Ronald Dekker joined Philips Research in 1988 where he worked on the development of IC technologies. Since 2000 his focus shifted to the integration of complex electronic sensor functionality on the tip of smart catheters. In 2007 he was appointed part time professor at the Technical University of Delft with a focus on Organ-on-Chip and bioelectronics medicines. Since 2013 he has been the initiator of a number of large European initiatives that all have in common the development of open technology platforms for electronic medical devices.

Back to session overview